Cargando…

Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study

BACKGROUND: Many patients with schizophrenia and bipolar disorder have impaired insight and low medication adherence. The aim of this post hoc analysis was to explore the relationship between insight and medication adherence. METHODS: We included 903 patients with schizophrenia or bipolar disorder w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novick, Diego, Montgomery, William, Treuer, Tamas, Aguado, Jaume, Kraemer, Susanne, Haro, Josep Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524170/ https://www.ncbi.nlm.nih.gov/pubmed/26239486 http://dx.doi.org/10.1186/s12888-015-0560-4

Ejemplares similares

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
por: Novick, Diego, et al.
Publicado: (2017)

Sex differences in the course of schizophrenia across diverse regions of the world
por: Novick, Diego, et al.
Publicado: (2016)

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia
por: Hong, Jihyung, et al.
Publicado: (2013)

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients
por: Novick, Diego, et al.
Publicado: (2016)

Empirically driven definitions of “good,” “moderate,” and “poor” levels of functioning in the treatment of schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2012)

Risk factors for suicide behaviors in the observational schizophrenia outpatient health outcomes (SOHO) study
por: Brugnoli, Roberto, et al.
Publicado: (2012)

Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia
por: Hong, Jihyung, et al.
Publicado: (2014)

Schizophrenia Outpatient Health Outcomes study: twelve-month findings
por: Novick, Diego, et al.
Publicado: (2012)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
por: Hong, Jihyung, et al.
Publicado: (2012)

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
por: Xue, Hai Bo Haber, et al.
Publicado: (2014)

Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?
por: Hong, Jihyung, et al.
Publicado: (2015)

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
por: Ascher-Svanum, Haya, et al.
Publicado: (2014)

Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties
por: Zhao, Jingping, et al.
Publicado: (2014)

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting
por: Hong, Jihyung, et al.
Publicado: (2015)

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
por: Treuer, Tamás, et al.
Publicado: (2016)

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study
por: Novick, Diego, et al.
Publicado: (2015)

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
por: Novick, Diego, et al.
Publicado: (2017)

Evaluation of treatment adherence in outpatients with schizophrenia
por: Chaudhari, Bhushan, et al.
Publicado: (2017)

Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties
por: Montgomery, William, et al.
Publicado: (2012)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

The personal, societal, and economic burden of schizophrenia in the People’s Republic of China: implications for antipsychotic therapy
por: Montgomery, William, et al.
Publicado: (2013)

Insights into myelin dysfunction in schizophrenia and bipolar disorder
por: Valdés-Tovar, Marcela, et al.
Publicado: (2022)

Association between Therapeutic Alliance and Adherence in Outpatient Schizophrenia Patients
por: Chang, Jhin Goo, et al.
Publicado: (2019)

Identifying Poor Adherence in Outpatients with Bipolar Disorder: A Comparison of Different Measures
por: Chauhan, Nidhi, et al.
Publicado: (2021)

Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
por: Ye, Wenyu, et al.
Publicado: (2014)

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
por: Novick, Diego, et al.
Publicado: (2013)

Insight, symptom severity and medication adherence in bipolar disorder
por: Abdelhamid, A., et al.
Publicado: (2023)

Association between Medication Adherence and Duration of Outpatient Treatment in Patients with Schizophrenia
por: Tarutani, Seiichiro, et al.
Publicado: (2016)

Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why
por: Gibson, Susanne, et al.
Publicado: (2013)

Impact of insight quality on treatment adherence in schizophrenia
por: Rami, A., et al.
Publicado: (2023)

Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia
por: Domenech, Cristina, et al.
Publicado: (2019)

Theory of Mind in Bipolar Disorder, with Comparison to the Impairments Observed in Schizophrenia
por: Mitchell, Rachel L. C., et al.
Publicado: (2016)

Measuring cognitive insight in schizophrenia and bipolar disorder: a comparative study
por: Engh, John A, et al.
Publicado: (2007)

Medication adherence and cognitive performance in schizophrenia-spectrum and bipolar disorder: results from the PsyCourse Study
por: Senner, Fanny, et al.
Publicado: (2023)

Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
por: Stephenson, J J, et al.
Publicado: (2012)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick, Diego, et al.
Publicado: (2016)

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
por: Montgomery, William, et al.
Publicado: (2014)

Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia
por: Kim, Jong-Hoon, et al.
Publicado: (2015)

A Cross-sectional, Comparative Study of Insight in Schizophrenia and Bipolar Patients in Remission
por: Ramachandran, Arul Saravanan, et al.
Publicado: (2016)

Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study
por: Kutzelnigg, Alexandra, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hsn402g961183rgkhgg874uc58